Effect of Marble Play on Handgrip Strength and Handwriting Among School Going Children. (NCT07331675) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of Marble Play on Handgrip Strength and Handwriting Among School Going Children.
Pakistan46 participantsStarted 2025-12-22
Plain-language summary
This study aims to address the effects of a Marble Play on the handgrip strength and handwriting skills of primary school children, providing empirical evidence for a cost-effective and culturally relevant therapeutic tool. This study will be a randomized controlled trial. A total of 46 children from Grades 1-3 will be recruited via convenience sampling and randomly assigned to either an experimental group (n=23) or a control group (n=23).The experimental group will participate in one-on-one sessions of Marble Play game with
.The control group will continue with their regular free play activities. The primary assessment tools will be the Evaluation Tool of Children's Handwriting (ETCH) to measure writing legibility and speed, and a hand-held dynamometer to measure hand grip strength.
Who can participate
Age range
6 Years – 9 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children enrolled in Grade 1-3 (typically aged 6-9 years)
* Children with normal cognitive development, as assessed by school records or teacher reports
* Students with average or below average handwriting fluency (based on teacher observation or pre-test).
* Parental or guardian consent obtained for participation.
* Regular school attendance and ability to participate in intervention sessions.
Exclusion Criteria:
* Children with significant visual or motor impairments that may affect fine motor coordination.
* Participants with a known history of dust allergy or diagnosed allergic rhinitis triggered by dust exposure will be excluded.
* Individuals with a current or recent (within the last 6 months) fracture of any upper, wrist, or hand) will be excluded.
* Students with a history of behavioral issues that would prevent consistent participation in structured play.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.